跳至主要内容
临床试验/NCT01575639
NCT01575639已完成3 期

Randomized Trial of High Dose (4mg/kg) Versus Usual Dose (2mg/kg) Oral Prednisolone in the Treatment of Infantile Spasms.

Lady Hardinge Medical College1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2012年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
63
试验地点
1
主要终点
Proportion of children who achieved spasm freedom (for at least 48 hours) as per parental reports on day 14 .

研究概览

简要总结

Infantile spasms comprise a difficult to treat type of epilepsy in young children. Hormonal treatment, i.e. Prednisolone and ACTH are considered the treatment of choice. There is no consensus on the dosage of Prednisolone required for the treatment of infantile spasms. Recent data has shown that a high dose (4 mg/kg/day) may be more efficacious than the usual dose (2 mg/kg/day). However, there are no randomized controlled trials comparing these doses. A higher steroid dose may also be associated with more side effects. Therefore, this study was planned to compare the efficacy and tolerability of the high dose versus the usual dose in children with infantile spasms, in a randomized open-label trial design

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Months 至 24 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Children aged 3 months to 2 years presenting with epileptic spasms (at least 1 cluster/day) with EEG evidence of hypsarrhythmia or its variants

排除标准

  • Children with active systemic illness
  • Children with evidence of active tuberculosis
  • Severe Acute Malnutrition ad defined by WHO (visible wasting/Mid Upper Arm Circumference < 11 cm/pedal edema/Weight for height < 3 SD)
  • Children with recurrent illness/chronic systemic illness

研究组 & 干预措施

High dose

Experimental

Oral Prednisolone will be given at dose of 4 mg/kg/day for 14 days

干预措施: Oral prednisolone (Drug)

Usual dose

Active Comparator

Oral prednisolone will be given at dose of 2 mg/kg/day for 14 days

干预措施: Oral prednisolone (Drug)

结局指标

主要结局

Proportion of children who achieved spasm freedom (for at least 48 hours) as per parental reports on day 14 .

时间窗: 14 days

次要结局

  • Proportion of children with adverse effects(14 days)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Satinder Aneja

Director Professor

Lady Hardinge Medical College

研究点 (1)

Loading locations...

相似试验